Glycobreez-F HPMC Capsule 10's

Glycobreez-F HPMC Capsule is used for long-term maintenance treatment of Chronic Obstructive Pulmonary Disease (COPD). COPD is a group of lung diseases with emphysema (shortness of breath) and chronic bronchitis (inflammation of the bronchial tube lining).

Glycobreez-F HPMC Capsule is a combination of Formoterol fumarate and Glycopyrronium. Formoterol fumarate prevents airway muscle contraction, making it easier for air to enter and exit the lungs. Glycopyrronium decreases the secretions in the airways.

In some cases, you may experience common side effects such as headache, nausea, dry mouth, chest pain, muscle cramps, dizziness, and frequent urination. Most of these side effects do not require medical attention. However, talk to your doctor if the side effects persist or worsen.

Do not stop taking Glycobreez-F HPMC Capsule on your own, as it might cause worsening of symptoms. Consult your doctor if you are pregnant or breastfeeding. Glycobreez-F HPMC Capsule is not recommended for children under 18 years old, as safety and effectiveness have not been established. Keep your doctor informed about your health condition and the medicines you are taking to avoid unpleasant side effects.

Glycobreez-F HPMC Capsule is used to treat chronic obstructive pulmonary disease (COPD). The detailed uses of Glycobreez-F HPMC Capsule are as follows:

• Management of chronic obstructive pulmonary disease: Glycobreez-F HPMC Capsule helps improve airflow and reduce symptoms in patients with COPD.
• Relief of breathing difficulty: This inhalation therapy relaxes airway muscles, making breathing easier in conditions such as chronic bronchitis and emphysema.
• Control of airway inflammation: Glycobreez-F HPMC Capsule reduces inflammation and prevents airway narrowing.
• Prevention of COPD exacerbations: Regular use reduces the frequency and severity of flare-ups in patients with COPD.
• Improvement of lung function: This combination improves overall respiratory capacity and enhances physical exercise tolerance.
• Maintenance therapy in long-term respiratory conditions: It is used as long-term maintenance treatment to control obstructive airway diseases.

• Follow your doctor's instructions on the dosage and timing of this medication to ensure safe and effective use.
• Check the label for instructions before using this medication. Place Glycobreez-F HPMC Capsule at the base of the inhaler and twist the mouthpiece until you hear a clicking sound. Breathe deeply through the mouthpiece and hold your breath for 10 seconds.
• Glycobreez-F HPMC Capsule is for oral inhalation only. Do not swallow Glycobreez-F HPMC Capsule .
• Rinse your mouth with water and spit it out after using Glycobreez-F HPMC Capsule to avoid fungal infections in the mouth and throat.

• Glycobreez-F HPMC Capsule is a combination of two medicines, namely: Formoterol fumarate and Glycopyrronium.
• Glycobreez-F HPMC Capsule belongs to the group of medicines called bronchodilators, used to treat Chronic Obstructive Pulmonary Disease (COPD).
• Formoterol fumarate is a long-acting beta-agonist that prevents the tightening of airway muscles, making it easier for air to enter and exit the lungs.
• Glycopyrronium is an anti-cholinergic that decreases the secretions in the airways.

• Do not use Glycobreez-F HPMC Capsule if you are allergic to any of its contents.
• Inform your doctor if you have asthma, heart problems, seizures/epilepsy, thyroid gland problems, diabetes, narrow-angle glaucoma, kidney problems, severe liver problems, if you have any difficulty in passing urine or if you are taking any medicines for lung diseases.
• Consult your doctor if you are pregnant or breastfeeding.
• Glycobreez-F HPMC Capsule may cause dizziness, so drive with caution.
• Avoid consuming alcohol, as it might cause increased dizziness.
• Glycobreez-F HPMC Capsule is not recommended for children below 18 years, as safety and effectiveness have not been established.